The Access to Medicine Foundation stimulates and guides pharmaceutical companies to do more for the people living in low- and middle-income countries without access to medicine.
I’ve been impressed by the Access to Medicine Index. It presents well-balanced stakeholder views on good practices for the pharmaceutical industry and it provides clear standards against which the performance of individual companies can be judged.
President, Realizing Rights, Former UN High Commissioner for Human Rights (1997-2002), Former President of Ireland (1990-1997)
The Access to Medicine Index is a very important project. What gets measured, gets done.
Former Director General, World Health Organisation
When I talk to executives from pharmaceutical companies they tell me that they want to do more for neglected diseases, but they at least need to get credit for it. The Access to Medicine Index does exactly that.
Co-chair and Trustee, Bill & Melinda Gates Foundation
View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.
